Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials
2019 · Clinical Infectious Diseases · 723 citations
https://doi.org/10.1093/cid/ciz999
M
Moupali Das
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
5.3K
Citations
33
h-index
51
i10-index
Moupali Das is an academic researcher. The author has contributed to research in topics: HIV/AIDS Research and Interventions & HIV/AIDS drug development and treatment & HIV, Drug Use, Sexual Risk. The author has an h-index of 33, co-authored 84 publications.
ORCID: 0000-0001-5034-8185Papers by this author
worksTwice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women
2024 · New England Journal of Medicine · 373 citations
https://doi.org/10.1056/nejmoa2407001
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019
2020 · Clinical Infectious Diseases · 120 citations
https://doi.org/10.1093/cid/ciaa1466
Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials
2021 · Clinical Infectious Diseases · 112 citations
https://doi.org/10.1093/cid/ciab444
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial
2021 · The Lancet HIV · 88 citations
https://doi.org/10.1016/s2352-3018(21)00071-0
Aripiprazole for the treatment of methamphetamine dependence: a randomized, double‐blind, placebo‐controlled trial
2012 · Addiction · 60 citations
https://doi.org/10.1111/add.12073
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat